<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to evaluate the prognostic significance of lymphatic invasion in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> that have already spread to regional lymph nodes </plain></SENT>
<SENT sid="1" pm="."><plain>168 patients with node-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (colon, n=98; rectum, n=70) were retrospectively evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>Lymphatic invasion was assessed on H&amp;E stained slides and univariable and multivariable analyses were applied </plain></SENT>
<SENT sid="3" pm="."><plain>Lymphatic invasion was detected in 95 (57%) cases and was significantly associated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and node classification and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> differentiation </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> showing lymphatic invasion had decreased progression-free survival (p=0.025) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival (p=0.082) </plain></SENT>
<SENT sid="5" pm="."><plain>Stratified by location, lymphatic invasion was significantly associated with decreased progression-free (p=0.010) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific (p=0.023) survival in <z:hpo ids='HP_0003003'>colon cancers</z:hpo>, yet not in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariable analysis proved T4 (HR 2.18, 95% CI 1.40 to 3.39; p&lt;0.001) and N2 (HR 1.68, 95% CI 1.07 to 2.66; p=0.03) as independent predictors of progression-free survival and T4 (HR 1.90, 95% CI 1.17 to 3.07; p=0.009), N2 (HR 2.27, 95% CI 1.38 to 3.73; p=0.001) and poor <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> differentiation (HR 2.18, 95% CI 1.39 to 3.43; p&lt;0.001) as independent predictors of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival, while for lymphatic invasion no influence on outcome was noted </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, only <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and node classification, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> differentiation proved to be independent prognostic variables in node-positive <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and merit special attention in clinical decision-making </plain></SENT>
</text></document>